Selenium and glutathione peroxidase with beta-thalassemia major

Nursing Research

Volumn 50, Issue 3, 2001, Pages 178-183

  Bartlay, Wally J ^a   Bartfay, Emma ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Beta thalassemia; Glutathione; Peroxidase selenium

Indexed keywords

CHELATING AGENT; DEFEROXAMINE; GLUTATHIONE PEROXIDASE; SELENIUM;

ADULT; ARTICLE; BETA THALASSEMIA; BLOOD; CASE CONTROL STUDY; CHELATION THERAPY; FEMALE; HUMAN; MALE;

ADULT; BETA-THALASSEMIA; CASE-CONTROL STUDIES; CHELATING AGENTS; CHELATION THERAPY; DEFEROXAMINE; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; MALE; SELENIUM;

EID: 0035348724     PISSN: 00296562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006199-200105000-00009     Document Type: Article

References (31)

1. Arthur, J. R. (1992). Selenium metabolism and function. Proceedings of the Nutritional Society of Australia, 17, 91-98.
2. Bartfay, W.J., Butany, J., Sole, M.J., Hou, D., Bartfay, E., & Liu, P.P. (1999). A biochemical, histochemical, and electron microscopic study on the effects of iron-loading in heart of mice. Cardiovascular Pathology, 8(6), 305-314.
3. Bartfay, W.J., Dawood, F.D., Wen, W.H., Lehotay, D.C., Hou, D., Bartfay, E., Luo, X.P., Backx, P.H., & Liu, P.P. (1999). Cardiac function and cytotoxic aldehyde production in a murme model of chronic iron-overload. Cardiovascular Research, 43, 892-900.
4. Bartfay, W.J., Hou, D., Brittenham, G.M., Bartfay, E., Sole, M.J., Lehotay, D.C., & Liu, P.P. (1998). The synergistic effects of vitamin E and selenium in iron-loaded mouse hearts. Canadian Journal of Cardiology, 14, 937-941.
5. Bartfay, W.J., Lehotay, D.C., Sher, G.D., Bartfay, E., Tyler, B., Luo, X.P., & Liu, P.P. (1999). Comparison of cytotoxic aldehyde generation in beta-thalassemia patients chelated with deferoxamine or deferiprone (L1) versus no chelation. Hematology, 4, 67-76.
6. Byler, R.M., Sherman, N.A., Wallner, J.S., & Horwitz, L.D. (1994). Hydrogen peroxide cytotoxicity is iron dependent. American Journal of Physiology, 35, H121-H127.
7. Chareopong-Kawamoto, N., & Yasumoto, K. (1995). Selenium deficiency as a cause of overload of iron and unbalance distribution of other minerals. Bioscience, Biotechnology and Biochemistry, 59, 302-306.
8. Dworkin, B.M. (1994). Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS). Chemico-Biologica International, 91, 181-186.
9. Feder, J. N., Gnirke, A., Thomas, W., Tsuchihasi, Z., Ruddy, D.A., Vasaua, A., & Dormishian, F. (1996). A novel class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genetics, 13, 399-408.
10. Herbert, V., Shaw, S., Jayatilleke, E., & Stopler-Kasdan, T. (1994). Most free radical injury is iron-related: It is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferoxamine and apoferritin. Stem Cells, 12, 289-303.
11. Lesnefsky, E.J. (1994). Tissue iron overload and mechanisms of iron-catalyzed oxidative injury. Advances in Experimental Medicine and Biology, 366, 129-146.
12. Levender, O. A., & Beck, M. A. (1997). Interacting nutritional and infectious etiologies of Keshan disease. Insights from coxsackie virus B-induced myocarditis in mice deficient in selenium and vitamin E. Biology of Trace Element Research, 56, 5-21.
13. Liu, P., & Olivieri, N. (1994). Iron-overload cardiomyopathies: New insights into an old disease. Cardiovascular Drugs and Therapy, 8, 101-110.
14. Livrea, M.A., Tesoriere, L., Pintaudi, A.M., Calabrese, A., Maggio, A., Freisleben, H.J., D-Arpa, D., D'Anna, R., & Bongiorno, A. (1996). Oxidative stress and antioxidant status in beta-thalassemia major: Iron overload and depletion of lipid-soluble antioxidants. Blood, 88, 3608-3614.
15. Loebstein, R., Lehotay, D.C., Lou, X.P., Bartfay, W., Tyler, B., & Sher, G.D. (1998). Diabetic nephropathy in hypertransfused patients with β-thalassemia: The role of oxidative stress. Diabetes Care, 21, 1306-1309.
16. Lynch, S. R. (1995). Iron-overload: Prevalence and impact on health. Nutrition Reviews, 53, 255-260.
17. McCord, J. M. (1996). Effects of positive iron status at a cellular level. Nutrition Reviews, 54, 85-88.
18. Mitchiel, C., Raes, M., Toussaint, O., & Remade, J. (1994). Importance of Se-glutathione peroxidase, catalase, and Cu/Zu-SOD for cell survival against oxidative stress. Free Radical Biology and Medicine, 17, 235-248.
19. rd ed.). Toronto: John Wiley & Sons.
20. Olivieri, N., & Brittenham, G.M. (1997). Iron-chelating therapy and the treatment of thalassemia. Blood, 89, 281-284.
21. Oster, O., & Prellwitz, W. (1990). Selenium and cardiovascular disease. Biology of Trace Element Research, 24, 91-103.
22. Parkkila, S., Niemela, O., Britton, R.S., Brown, K.E., & Yla-Herttuala, S. (1996). Vitamin E decreases hepatic levels of aldehyde-derived peroxidation products in rats with iron-overload. American Journal of Physiology, 270, G376-G384.
23. Read, R., Bellew, T., Yang, J.G., Hill, K.E., Palmer, I.S., & Burk, R.F. (1990). Selenium and amino acid composition of selenoprotein P, the major selenoprotein in rat serum. Journal of Biology and Chemistry, 265, 17899-17905.
24. Salonen, J. T. (1987). Selenium in ischaemic heart disease. International Journal of Epidemiology, 16, 323-327.
25. Salonen, J. T., Salonen, R., Lappetelainen, R., Maenpaa, P.H., Alfthan, G., & Puska, P. (1985). Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: Matched case-control analysis of prospective data. British Medical Journal, 290, 417-420.
26. Scott, M.D., van den Berg, J.J. M., Repka, T., Rouyer-Fessard, P., Hebbel, R.P., Beuzard, Y., & Lubin, B.H. (1993). Effect of excess α-hemoglobin chains on cellular and membrane oxidation in model β-thalassemic erythrocytes. Journal of Clinical Investigations, 91, 1706-1712.
27. Starke, P. E., & Faber, J. L. (1985). Ferric iron and superoxide ions are required for the killing of cultured hepatocytes by hydrogen peroxide: Evidence for the participation of hydroxyl radicals formed by iron-catalyzed Haber Weiss reaction. Journal of Biology and Chemistry, 260, 10099-10104.
28. U.K. Thalassemia Society (1993). All you need to know about the beta-thalassemia trait. London: U.K. Thalassemia Society.
29. Whanger, P.D. (1993). Selenium in the treatment of heavy metal poisoning and chemical carcinogenesis. Journal of Trace Elements, Electrolytes, Health and Disease, 6, 209-212.
30. Xia, Y., Piao, J., Hill, K.E., & Burk, R.F. (1994). Keshan disease and selenium status of populations in China. In: R.F. Burk (Ed.), Selenium in Biology and Human Health (pp. 181-196). New York: Springer-Verlag.
31. Young, I.S., Trouton, T.G., Torney J.J., McMaster, D., Callender M., & Trimble, E.R. (1994). Antioxidant status and lipid peroxidation in hereditary hemochromatosis. Free Radical Biology and Medicine, 16, 393-397.